Eurasia
Regional Overview
Following a rapid increase in injecting drug use during the 1990s, Central and Eastern Europe and Central Asia (or ‘Eurasia’) witnessed the fastest growing HIV epidemics in the world. Since 2001, the number of people living with HIV in the region has more than doubled, from 630,000 to 1.6 million. As a response to rapidly expanding HIV epidemics,… Read more
Injecting Drug Use, HIV and Hepatitis C
The following maps and table outline the current available data on injecting drug use, as well as the prevalence of HIV and hepatitis C among injecting populations in ‘Eurasia’. The map below illustrates HIV prevalence among injecting drug users in countries of the region. The map below illustrates hepatitis C prevalence among injecting… Read more
Harm Reduction Policies
Most countries in this region have an explicit supportive reference to harm reduction in their national policies on HIV and/or drugs. These are illustrated in the map and table below. Although policy wording is not necessarily indicative of the implementation of effective harm reduction measures in a country, it does indicate governmental… Read more
Harm Reduction Programmes
Key harm reduction interventions (including needle and syringe exchange and opioid substitution therapy) are available in almost all countries in this region, as illustrated in the maps and table below. Crucially however, coverage remains low in many countries and the sustainability of funds for harm reduction programmes continues to be an issue.… Read more